JP2021521120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021521120A5 JP2021521120A5 JP2020555100A JP2020555100A JP2021521120A5 JP 2021521120 A5 JP2021521120 A5 JP 2021521120A5 JP 2020555100 A JP2020555100 A JP 2020555100A JP 2020555100 A JP2020555100 A JP 2020555100A JP 2021521120 A5 JP2021521120 A5 JP 2021521120A5
- Authority
- JP
- Japan
- Prior art keywords
- exist
- phenyl
- here
- cancer
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC*(C)CN*CC(C)* Chemical compound CC*(C)CN*CC(C)* 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023131904A JP2023138858A (ja) | 2018-04-11 | 2023-08-14 | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ－トリアジン誘導体および／またはピラゾロ－ピリミジン誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862656070P | 2018-04-11 | 2018-04-11 | |
| US62/656,070 | 2018-04-11 | ||
| PCT/EP2019/059302 WO2019197549A1 (en) | 2018-04-11 | 2019-04-11 | Pyrazolo-triazine and/or pyrazolo-pyrimidine derivatives as selective inhibitor of cyclin dependent kinase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023131904A Division JP2023138858A (ja) | 2018-04-11 | 2023-08-14 | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ－トリアジン誘導体および／またはピラゾロ－ピリミジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521120A JP2021521120A (ja) | 2021-08-26 |
| JP2021521120A5 true JP2021521120A5 (enExample) | 2021-11-11 |
| JP7772501B2 JP7772501B2 (ja) | 2025-11-18 |
Family
ID=66334385
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555100A Active JP7772501B2 (ja) | 2018-04-11 | 2019-04-11 | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ－トリアジン誘導体および／またはピラゾロ－ピリミジン誘導体 |
| JP2023131904A Pending JP2023138858A (ja) | 2018-04-11 | 2023-08-14 | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ－トリアジン誘導体および／またはピラゾロ－ピリミジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023131904A Pending JP2023138858A (ja) | 2018-04-11 | 2023-08-14 | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ－トリアジン誘導体および／またはピラゾロ－ピリミジン誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11945822B2 (enExample) |
| EP (1) | EP3774810A1 (enExample) |
| JP (2) | JP7772501B2 (enExample) |
| KR (1) | KR102966455B1 (enExample) |
| CN (1) | CN112313235A (enExample) |
| AU (1) | AU2019250507B2 (enExample) |
| BR (1) | BR112020020768A2 (enExample) |
| CA (1) | CA3095880A1 (enExample) |
| IL (1) | IL277770B2 (enExample) |
| MX (1) | MX2020010675A (enExample) |
| MY (1) | MY199647A (enExample) |
| PH (1) | PH12020551639A1 (enExample) |
| SG (1) | SG11202009724YA (enExample) |
| WO (1) | WO2019197549A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220144841A1 (en) * | 2019-03-13 | 2022-05-12 | The Translational Genomics Research Institute | Trisubstituted pyrazolo [1,5-a] pyrimidine compounds as cdk7 inhibitors |
| EP3725788A1 (en) * | 2019-04-15 | 2020-10-21 | Bayer AG | Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides |
| TW202146416A (zh) * | 2019-12-11 | 2021-12-16 | 德商拜耳廠股份有限公司 | 吡唑并三𠯤 |
| GB201918541D0 (en) | 2019-12-16 | 2020-01-29 | Carrick Therapeutics Ltd | Therapeutic compounds and their use |
| US20230115907A1 (en) | 2019-12-20 | 2023-04-13 | Evopoint Biosciences Co., Ltd. | Heterocyclic compound and pharmaceutical composition, preparation method, intermediate and use thereof |
| CA3174507A1 (en) * | 2020-03-06 | 2021-09-10 | Bayer Aktiengesellschaft | Imidazotriazines acting on cancer via inhibition of cdk12 |
| CN112079781B (zh) * | 2020-09-30 | 2022-11-22 | 苏州康润医药有限公司 | 5-溴-1-甲基-1h-吡唑-3-胺的合成方法 |
| EP4255909A1 (en) | 2020-12-02 | 2023-10-11 | Qurient Co. Ltd. | Compounds having cyclin-dependent kinase(cdk)-inhibitory function |
| GB202108572D0 (en) * | 2021-06-16 | 2021-07-28 | Carrick Therapeutics Ltd | Therapeutic compounds and their use |
| CN114195710A (zh) * | 2021-12-20 | 2022-03-18 | 上海彩迩文生化科技有限公司 | 一种喹啉类胺甲基化合物的制备方法 |
| WO2024151112A1 (ko) * | 2023-01-11 | 2024-07-18 | 주식회사 티움바이오 | 사이클린 의존성 키나아제 9 저해제로서의 피라졸로피리미딘 유도체 |
| CN120712267A (zh) * | 2023-02-21 | 2025-09-26 | 杭州德睿智药科技有限公司 | 作为CDKs抑制剂的新型并杂环类新化合物及其应用 |
| KR102912267B1 (ko) * | 2023-04-20 | 2026-01-15 | 한국화학연구원 | 신규한 헤테로고리 화합물 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물 |
| WO2025024726A1 (en) * | 2023-07-26 | 2025-01-30 | Kinnate Biopharma Inc. | Inhibitors of cyclin-dependent kinase |
| CN117756747A (zh) * | 2023-12-21 | 2024-03-26 | 济宁医学院 | 一种n-苯基含氮多元环季铵盐类化合物的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US615968A (en) | 1898-12-13 | Apparatus for treating ores | ||
| US7563798B2 (en) * | 2002-09-04 | 2009-07-21 | Schering Corporation | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors |
| CN100376580C (zh) * | 2002-09-04 | 2008-03-26 | 先灵公司 | 作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶 |
| US8673924B2 (en) * | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
| US7119200B2 (en) | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| US7205308B2 (en) * | 2002-09-04 | 2007-04-17 | Schering Corporation | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| TW200536536A (en) * | 2004-02-25 | 2005-11-16 | Schering Corp | Pyrazolotriazines as kinase inhibitors |
| JP2009007342A (ja) * | 2007-06-01 | 2009-01-15 | Mitsubishi Tanabe Pharma Corp | 医薬組成物 |
| JP2010529140A (ja) * | 2007-06-05 | 2010-08-26 | エモリー・ユニバーシテイ | サイクリン依存性キナーゼの選択的阻害剤 |
| EP2634189A1 (en) * | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| EP2634190A1 (en) * | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors |
| GB201403093D0 (en) * | 2014-02-21 | 2014-04-09 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| EP3805218A1 (en) | 2014-04-05 | 2021-04-14 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| EP3268000B1 (en) * | 2015-03-09 | 2021-08-04 | Aurigene Discovery Technologies Limited | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors |
| WO2019144149A2 (en) * | 2018-01-22 | 2019-07-25 | Fred Hutchinson Cancer Research Center | Treatment methods for pancreatic tumors associated with the worst prognosis |
-
2019
- 2019-04-11 KR KR1020207032379A patent/KR102966455B1/ko active Active
- 2019-04-11 EP EP19720425.8A patent/EP3774810A1/en active Pending
- 2019-04-11 WO PCT/EP2019/059302 patent/WO2019197549A1/en not_active Ceased
- 2019-04-11 MX MX2020010675A patent/MX2020010675A/es unknown
- 2019-04-11 JP JP2020555100A patent/JP7772501B2/ja active Active
- 2019-04-11 IL IL277770A patent/IL277770B2/en unknown
- 2019-04-11 CN CN201980039582.5A patent/CN112313235A/zh active Pending
- 2019-04-11 SG SG11202009724YA patent/SG11202009724YA/en unknown
- 2019-04-11 BR BR112020020768-3A patent/BR112020020768A2/pt unknown
- 2019-04-11 US US17/045,030 patent/US11945822B2/en active Active
- 2019-04-11 CA CA3095880A patent/CA3095880A1/en active Pending
- 2019-04-11 MY MYPI2020005130A patent/MY199647A/en unknown
- 2019-04-11 AU AU2019250507A patent/AU2019250507B2/en active Active
-
2020
- 2020-10-05 PH PH12020551639A patent/PH12020551639A1/en unknown
-
2023
- 2023-08-14 JP JP2023131904A patent/JP2023138858A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521129A5 (enExample) | ||
| JP2021521129A (ja) | 薬学的に活性なピラゾロ−トリアジン誘導体および／またはピラゾロ−ピリミジン誘導体 | |
| JP2021521120A (ja) | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ−トリアジン誘導体および／またはピラゾロ−ピリミジン誘導体 | |
| CN110372673B (zh) | 含酰肼的核运输调节剂及其用途 | |
| CA2882733C (en) | Novel 4,6-disubstituted aminopyrimidine derivatives having both aromatic and halogenic substituents | |
| US20260125362A1 (en) | Targeted protein degradation of parp14 for use in therapy | |
| ES2390710T3 (es) | Compuesto heterocíclico y composición farmacéutica del mismo | |
| US20160326138A1 (en) | Process for preparing an anti-cancer agent, 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts | |
| JP2022550436A (ja) | 抗ウイルス性複素環化合物 | |
| EP2138489B1 (en) | Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same | |
| JP2021529814A (ja) | 化学化合物 | |
| KR20120097508A (ko) | 벤조디아제핀 브로모도메인 억제제 | |
| TW202019408A (zh) | 稠合三環雜環化合物及其治療用途 | |
| ES2277098T3 (es) | Derivados de quinolina y aza-indol y su uso como ligandos para 5-ht6. | |
| WO2018130174A1 (zh) | 吡咯并[2,3-c]吡啶类衍生物、其制备方法及其在医药上的应用 | |
| CA2673183A1 (en) | Bicyclic pyrimidinones and uses thereof | |
| US20190062328A1 (en) | Bruton's tyrosine kinase inhibitors | |
| CN105934425A (zh) | Ebna1抑制剂和其使用方法 | |
| WO2019154177A1 (zh) | 嘧啶类化合物、其制备方法及其医药用途 | |
| RU2015144483A (ru) | N-(2-цианогетероциклил)пиразолопиридоны в качестве ингибиторов янус-киназы | |
| US20090012056A1 (en) | Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor | |
| WO2006077851A1 (ja) | キノロン誘導体又はその塩 | |
| US20240343732A1 (en) | Compounds for degradation of cyclin-dependent kinase 7(cdk7) | |
| JP2874987B2 (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
| JP2008532980A (ja) | アミド置換された６−フェニルフェナントリジン |